Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC3153
TNBC
Basal A
Mebendazole
12939.174
uM
0.09935
0.55943
-0.8642 -0.9370 0.6109 0.7618
0.9574
0.3466
HCC3153
TNBC
Basal A
Mebendazole
13583.174
uM
0.16580
0.26708
-0.6804 -0.5978 1.6495 0.6918
0.9714
0.3654
HCC3153
TNBC
Basal A
Methotrexate
DHFR
Metabolism
7466.085
uM
inf
inf
0.9627 0.9627 0.0000 0.0395
0.1367
0.8684
HCC3153
TNBC
Basal A
Methotrexate
DHFR
Metabolism
7467.084
uM
inf
0.03588
0.6430 0.6163 5.0000 0.2732
0.9561
1.3029
HCC3153
TNBC
Basal A
Methylglyoxal
13603.184
uM
29.55980
192.7650
-0.9947 -1.0000 0.5859 0.9435
0.9105
0.7451
HCC3153
TNBC
Basal A
MG-132
Proteasome
Proteasome
14131.189
uM
0.15568
0.17557
-0.9362 -0.4119 5.0000 0.7255
0.6239
1.2288
HCC3153
TNBC
Basal A
MG-132
Proteasome
Proteasome
14131.189
uM
0.15568
0.17557
-0.9362 -0.4119 5.0000 0.7255
0.6239
1.2288
HCC3153
TNBC
Basal A
MG-132
Proteasome
Proteasome
10577.145
uM
0.16260
0.21708
-0.9699 -0.9684 3.7276 0.8980
0.9970
0.9676
HCC3153
TNBC
Basal A
MG-132
Proteasome
Proteasome
10577.145
uM
0.16260
0.21708
-0.9699 -0.9684 3.7276 0.8980
0.9970
0.9676
HCC3153
TNBC
Basal A
MG-132
Proteasome
Proteasome
10937.145
uM
0.09992
0.14032
-0.9691 -0.9620 3.1600 0.9354
0.9998
1.2098
HCC3153
TNBC
Basal A
MG-132
Proteasome
Proteasome
10937.145
uM
0.09992
0.14032
-0.9691 -0.9620 3.1600 0.9354
0.9998
1.2098
HCC3153
TNBC
Basal A
Pevonedistat
NAE1
NAE1
10577.135
uM
0.49792
1.43970
-0.5825 -0.6584 0.7914 0.5413
0.9731
1.0749
HCC3153
TNBC
Basal A
Pevonedistat
NAE1
NAE1
10937.148
uM
0.22673
0.34167
-0.4268 -0.3439 1.2763 0.5453
0.9914
1.4600
HCC3153
TNBC
Basal A
Nelfinavir
13733.174
uM
6.79860
9.17240
-0.9963 -1.0000 3.6683 0.3309
0.9153
0.5093
HCC3153
TNBC
Basal A
Nelfinavir
12939.174
uM
2.09890
5.54180
-0.9996 -1.0000 1.1315 0.4041
0.9209
0.3466
HCC3153
TNBC
Basal A
Nelfinavir
13583.174
uM
6.17610
7.69370
-1.0000 -1.0000 5.0000 0.2044
0.9928
0.3654
HCC3153
TNBC
Basal A
Nilotinib
ABL
nRTK
10937.145
uM
inf
inf
1.0433 1.0433 0.0000 0.0136
0.0664
1.2098
HCC3153
TNBC
Basal A
Nilotinib
ABL
nRTK
10577.145
uM
inf
42.00360
0.5069 0.5067 5.0000 0.0778
0.8731
0.9676
HCC3153
TNBC
Basal A
NSC 663284
CDC25
CDC
10937.152
uM
1.82810
2.86270
-0.9740 -0.9703 2.4048 0.6175
0.9980
1.2272
HCC3153
TNBC
Basal A
NSC 663284
CDC25
CDC
10577.14
uM
2.4650
3.61860
-0.9817 -0.9832 2.8326 0.5933
0.9991
0.9722
HCC3153
TNBC
Basal A
NU6102
CDK1/2
CDK
10937.147
uM
16.94970
21.36330
-0.4976 -0.5386 3.1588 0.1309
0.9940
1.2614
HCC3153
TNBC
Basal A
Nutlin 3a
MDM2
MDM2
7465.066
uM
32.33410
65.23290
-0.0204 -1.0000 1.5653 0.1316
0.9304
1.2627
HCC3153
TNBC
Basal A
Nutlin 3a
MDM2
MDM2
7466.066
uM
42.15690
43.02170
0.1633 -0.0345 3.2879 0.0160
0.9771
0.9420
HCC3153
TNBC
Basal A
Nutlin 3a
MDM2
MDM2
7467.066
uM
28.84520
47.81640
-0.3469 -1.0000 2.1736 0.1248
0.9908
1.1956
HCC3153
TNBC
Basal A
Olomoucine II
CDK1
CDK
10937.147
uM
3.51070
7.18610
-0.8865 -0.9411 1.4778 0.4363
0.9962
1.2614